SCHEMBL28464096

SCHEMBL28464096

CC(=O)CCC(=O)CCC(=O)CCC(=O)CCC(=O)CCC(=O)CC1(c2nccc(CO)n2)CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28467928 0.99 — —
SCHEMBL28473481 0.98 — —
SCHEMBL28469965 0.80 SMN1; SMN2 (0.37) —
SCHEMBL28470678 0.78 SMN1; SMN2 (0.37) —
SCHEMBL20745835 0.70 NUDT1 (0.31) —
SCHEMBL20745699 0.69 CCR1 (0.34) —
SCHEMBL22262721 0.68 CHRM2 (0.35) —
SCHEMBL20746024 0.67 KDM4C (0.33) —
SCHEMBL20745059 0.67 CHRM2 (0.34) —
SCHEMBL20745531 0.65 SLC22A12 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111818916-A Macrocyclic MCL-1 inhibitors and methods of use 艾伯维公司 2020-10-23 — — CN disclosed
Send feedback